Ginkgo Bioworks Holdings, Inc. (DNA) Options History
Historical options analytics archive for DNA with monthly max pain, implied volatility, gamma exposure, and put/call data.
84 months of complete options data available.
DNA monthly aggregates
Month-by-month rollups derived from the daily snapshot archive for DNA. Volatility and put/call columns are averages across trading days within the month; max pain, net GEX, and net DEX are the end-of-month values (last trading day of the month).
| Month | Days | Avg ATM IV | Avg IV Rank | End Max Pain | End Net GEX | End Net DEX | Avg P/C |
|---|---|---|---|---|---|---|---|
| 2026-06 | 21 | 101.7% | 25.2% | $9.00 | $113.0K | -$6.0M | 0.20 |
| 2026-05 | 20 | 116.7% | 40.7% | $8.00 | $59.2K | -$3.5M | 0.26 |
| 2026-04 | 21 | 121.5% | 46.2% | $8.00 | $20.3K | -$2.1M | 2.03 |
| 2026-03 | 22 | 104.7% | 28.0% | $7.00 | $5.0K | -$581.7K | 1.06 |
| 2026-02 | 19 | 115.5% | 38.7% | $10.00 | $21.4K | -$837.9K | 0.27 |
| 2026-01 | 20 | 99.6% | 23.0% | $10.00 | $42.1K | -$1.9M | 0.39 |
This archive aggregates DNA's daily end-of-day options snapshots into monthly summaries, spanning 2007-01 through 2026-06. Each month rolls up the underlying snapshot archive, which provides continuous end-of-day coverage from 2007 to present: implied-volatility levels, IV rank, and the put/call ratio are time-averaged across the month; total call and put volume are summed; and dealer positioning (net gamma and delta exposure) and the max-pain strike are taken at the month's final trading day. The result is a long-horizon view of how DNA option pricing, volatility regime, and dealer hedging pressure evolved month over month, useful for backtesting strategy assumptions and for studying volatility-regime shifts around earnings and macro events. The most recent aggregated month (2026-06) shows an average ATM implied volatility near 101.7%, a month-end max-pain strike around $9.00, an average put/call ratio of 0.20.
2026
Jan | Feb | Mar | Apr | May | Jun
2025
Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2024
Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2023
Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2022
Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2021
2009
2008
Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2007
Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
Frequently asked DNA history questions
- How much options history is available for DNA?
- This archive holds 84 months of DNA options analytics, spanning 2007-01 through 2026-06. Each entry is a monthly rollup of DNA's daily end-of-day options snapshot record, which provides continuous coverage from 2007 to present. Use the year-grouped links on this page to jump to any specific month within the DNA archive.
- What data does each monthly DNA aggregate contain?
- Every monthly row summarizes that month of DNA option activity: time-averaged ATM implied volatility and IV rank, the month-end max-pain strike, end-of-month net dealer gamma (GEX) and delta (DEX) exposure, the average put/call ratio, and total call and put volume. For example, 2026-06 recorded an average ATM implied volatility near 101.7%, an average IV rank of 25.2%, a month-end max-pain strike around $9.00, an average put/call ratio of 0.20.
- How is the DNA options-history archive built and how often does it update?
- The archive is derived from DNA's daily end-of-day options snapshots, which capture spot, the full listed chain, implied volatility, and dealer-positioning exposures each trading day. Those daily records are rolled up into the monthly summaries shown here and refreshed as new end-of-day data lands. Traders use the long-horizon view to backtest strategy assumptions, study how DNA's volatility regime shifts around earnings and macro events, and compare current dealer positioning against historical norms.